Skip to main content
Log in

Influence of pharmaceutical excipients on stability of pramipexole dihydrochloride monohydrate in tablets

  • Research Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the effect of the method of excipients addition (intra-granularly or extra-granularly) and type of excipients on the stability of pramipexole dihydrochloride monohydrate (PRM) tablets. Corn starch, pre-gelatinized starch, dibasic calcium phosphate, microcrystalline cellulose or lactose anhydrous were used as excipients. PRM tablets were prepared by a wet granulation method and stability tests were performed at 40 °C/75 % RH, 60 °C or 80 °C. X-ray diffraction (XRD), scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS) were used to characterize the physicochemical properties of PRM. While PRM raw material was inherently stable, decreased content and increased related substances were detected for PRM tablets. By incorporating pre-gelatinized starch with the drug intra-granularly, the most stable PRM tablet formulation was achieved. The results of XRD, SEM and EDS suggested that PRM was at the surface of granules with an amorphous state. In general, as the amorphous form is more reactive than the crystalline form, compatibility between PRM and the excipient plays an important role for drug stability in the tablet. Therefore, it is essential to select proper excipients to improve stability of PRM tablets prepared using the wet granulation method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Airaksinen S, Karjalainen M, Kivikero N, Westermarck S, Shevchenko A, Rantanen J, Yliruusi J (2005) Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation. AAPS PharmSciTech 6:311–322

    Article  Google Scholar 

  • Badawy SF, Gawronski AJ, Alvarez FJ (2001) Application of sorption–desorption moisture transfer modeling to the study of chemical stability of a moisture sensitive drug product in different packaging configurations. Int J Pharm 223:1–13

    Article  CAS  PubMed  Google Scholar 

  • Badawy S, Vickery R, Shah K, Hussain M (2004) Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate. Pharm Dev Technol 9:239–245

    Article  CAS  PubMed  Google Scholar 

  • Corrigan MH, Denahan AQ, Wright CE, Ragual RJ, Evans DL (2000) Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depression Anxiety 11:58–65

    Article  CAS  PubMed  Google Scholar 

  • Cunningham CR, Kinsey BR, Scattergood LK (2001) Formulation of acetylsalicylic acid tablets for aqueous enteric film coating. Pharm Technol Eur 13:44–53

    CAS  Google Scholar 

  • Delwiche SR, Pitt RE, Norris KH (1991) Examination of starch-water and cellulose-water interactions with near infrared (NIR) diffuse reflectance spectroscopy. Starch 43:415–422

    Article  CAS  Google Scholar 

  • Du J, Hoag SW (2001) The influence of excipients on the stability of the moisture sensitive drugs aspirin and niacinamide: comparison of tablets containing lactose monohydrate with tablets containing anhydrous lactose. Pharm Dev Technol 6:159–166

    Article  CAS  PubMed  Google Scholar 

  • Heidemann DR, Jarosz PJ (1991) Preformulation studies involving moisture uptake in solid dosage forms. Pharm Res 8:292–297

    Article  CAS  PubMed  Google Scholar 

  • Łaszcz M, Trzcińska K, Kubiszewski M, Kosmacińska B, Glice M (2010) Stability studies and structural characterization of pramipexole. J Pharm Biomed 53:1033–1036

    Article  Google Scholar 

  • Leentjens AG, Koester J, Fruh B, Shephard DS, Barone P, Houben JG (2009) The effect of pramipexole on mood and motivational symptoms in Parkinson’s disease: a meta-analysis of placebo-controlled studies. Clin Ther 31:89–98

    Article  CAS  PubMed  Google Scholar 

  • McCormack PL, Siddiqui MA (2007) Pramipexole: in restless legs syndrome. CNS drugs 21:429–437

    Article  CAS  PubMed  Google Scholar 

  • Mierau J, Schingnitz G (1992) Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Eur J Pharmacol 215:161–170

    Article  CAS  PubMed  Google Scholar 

  • Murikipudi V, Gupta P, Sihorkar V (2011) Efficient throughput method for hygroscopicity classification of active and inactive pharmaceutical ingredients by water vapor sorption analysis. Pharm Dev Technol 18:348–358

    Article  PubMed  Google Scholar 

  • Naidu KR, Kale UN, Shingare MS (2005) Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product. J Pharm Biomed 39:147–155

    Article  CAS  Google Scholar 

  • Q1A(R2) (2003) Q1A(R2) ICH guideline. Stability testing of new drug substances and products. International Conference on Harmonization, IFPMA, Geneva

  • Rowe RC, Sheskey PJ, Owen SC (2006) Handbook of pharmaceutical excipients. Pharmaceutical Press, London

    Google Scholar 

  • Schilling JC, Adamus WS, Palluk R (1992) Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans. Clin Pharmacol Ther 51:541–548

    Article  CAS  PubMed  Google Scholar 

  • USP (2013) USP36-NF31, US Pharmacopeial Convention, Rockville, MD

  • Vaucher LC, Paim CS, Lange AD, Schapoval EES (2009) LC method for telithromycin in tablets: a stability-indicating assay. Int J Pharm 366:82–87

    Article  CAS  PubMed  Google Scholar 

  • Villalobos-Hernandez J, Villafuerte-Robles L (2001) Effect of carrier excipient and processing on stability of indorenate hydrochloride/excipient mixtures. Pharm Dev Technol 6:551–561

    Article  CAS  PubMed  Google Scholar 

  • Wernersbach HW (2008) Process for preparing pramipexole dihydrochloride tablets with high storage stability. WO Patent 2,008,023,027

  • Wong KS, Lu CS, Shan DE, Yang CC, Tsoi TH, Mok V (2003) Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson’s disease. J Neurol Sci 216:81–87

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This article does not contain any studies with human and animal subjects performed by any of the authors. All authors (J.Y.Kim, J.M.Ha, Y.S. Rhee, C.W. Park, S.C, Chi, and E.S. Park) declare that they have no conflict of interest. This work was supported by the Korean Health Technology R&D Project, Ministry for Health and Welfare (A092018) and by the Ministry of Education, Science and Technology (MEST), the Ministry of Knowledge Economy (MKE) through the fostering project of HUNIC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eun-Seok Park.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, JY., Ha, JM., Rhee, YS. et al. Influence of pharmaceutical excipients on stability of pramipexole dihydrochloride monohydrate in tablets. Journal of Pharmaceutical Investigation 44, 177–185 (2014). https://doi.org/10.1007/s40005-013-0113-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-013-0113-0

Keywords

Navigation